Startup Iambic Raises $100M for Clinical Trials of AI-Discovered Cancer Drugs
Iambic’s latest financing follows the presentation of data for its breast cancer drug during the recent European Society of Medical Oncology conference. Our financing roundup includes capital raised by startups developing novel therapies immunology, metabolic disorders, genetic diseases, and more.
Late-in-Life Autism Diagnosis: Why Adults Still Face So Many Barriers and How We Can Do Better
Awareness of autism has grown, but we need to move beyond this into understanding and acceptance. Real progress depends on how we translate understanding into action — training more professionals, funding adult services, and redesigning workplaces and communities so autistic individuals can flourish throughout their lifespan.
Food Is Medicine Needs Data To Thrive
To make sure that Food is Medicine interventions are delivered the right way, we must be deliberate and proactive in how we collect and share data.
Merck Makes Big Antiviral Move With $9B Deal to Land Cidara’s Late-Stage Drug for Flu Prevention
Merck’s Cidara Therapeutics acquisition brings a lead program with potential to become a first-in-class drug for preventing influenza infection. A Phase 3 study is already underway, timed to coincide with the start of the flu season in the Northern Hemisphere.
Bridging the Gap Between Data and Quality Improvement for Hospitals
Data only drives change when the right people see the right numbers at the right time and someone owns the follow-through.